Basic Information | Post buying leads | Suppliers |
Name |
Dextrophan tartrate |
EINECS | N/A |
CAS No. | 143-98-6 | Density | g/cm3 |
PSA | 138.53000 | LogP | 0.89570 |
Solubility | N/A | Melting Point |
201-204°C |
Formula | C17H23NO•C4H6O6•H2O | Boiling Point | 410.4°Cat760mmHg |
Molecular Weight | 407.464 | Flash Point | 207.2°C |
Transport Information | N/A | Appearance | N/A |
Safety | Poison by intravenous route. Moderately toxic by subcutaneous route. When heated to decomposition it emits toxic fumes of NOx. | Risk Codes | R22; |
Molecular Structure | Hazard Symbols | Xn | |
Synonyms |
17methyl,tartrate(1:1)(salt),(+)morphinan3o;d3hydroxynmethylmorphinantartrate;dat;dextrophantartrate;DEXTRORPHANDTARTRATE((+)3HYDROXYNMETH;Dextrorphan,TartrateSalt;Dextrorphan,TartrateSalt |
Product Name: Dextrophan tartrate (CAS NO.143-98-6)
Molecular Formula: C21H29NO7
Molecular Weight: 407.45746g/mol
Mol File: 143-98-6.mol
Appearance: White Solid
Boiling point: 647.6 °C at 760 mmHg
Storage Temperature: −70°C
Flash Point: 345.4 °C
Enthalpy of Vaporization: 100.34 kJ/mol
Vapour Pressure: 1.19E-17 mmHg at 25°C
H-Bond Donor: 5
H-Bond Acceptor: 8
Structure Descriptors of Dextrophan tartrate (CAS NO.143-98-6):
Canonical SMILES: CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)O.C(C(C(=O)O)O)(C(=O)O)O
Isomeric SMILES: CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)O.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
InChI: InChI=1S/C17H23NO.C4H6O6/c1-18-9-8-17-7-3-2-4-14(17)16(18)10-12-5-6-13(19)11-15(12)17;5-1(3(7)8)2(6)4(9)10/h5-6,11,14,16,19H,2-4,7-10H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)/t14-,16+,17+;1-,2-/m11/s1
InChIKey: RWTWIZDKEIWLKQ-XCPWPWHNSA-N
Product Categories: Intermediates & Fine Chemicals; Pharmaceuticals
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intravenous | 42mg/kg (42mg/kg) | "Synthetic Analgesics," Oxford, Pergamon Press, 1966Vol. 2, Pg. 77, 1966. | |
mouse | LD50 | oral | 385mg/kg (385mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 109, Pg. 189, 1953. | |
mouse | LD50 | parenteral | 17414ug/kg (17.414mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 145, Pg. 11, 1964. | |
mouse | LD50 | subcutaneous | 350mg/kg (350mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 109, Pg. 189, 1953. | |
rabbit | LD50 | intravenous | 27500ug/kg (27.5mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS LUNGS, THORAX, OR RESPIRATION: DYSPNEA BEHAVIORAL: REGIDITY | Journal of Pharmacology and Experimental Therapeutics. Vol. 109, Pg. 189, 1953. |
rat | LD50 | oral | 1100mg/kg (1100mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 109, Pg. 189, 1953. | |
rat | LD50 | subcutaneous | 800mg/kg (800mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 109, Pg. 189, 1953. |
Poison by ingestion, subcutaneous, and intravenous routes. When heated to decomposition it emits toxic fumes of NOx.
Safety Information of Dextrophan tartrate (CAS NO.143-98-6):
Hazard Codes: Xn
Risk Statements: 22
22: Harmful if swallowed
Dextrophan tartrate ,its CAS NO. is 143-98-6,the synonyms is 1,3,4,9,10,10a-Hexahydro-11-methyl-2H-10,4a-iminoethanophenanthren-6-ol tartrate, d- ; Ro 1-6794 ; d-3-Hydroxy-N-methylmorphinan tartrate ; Morphinan-3-ol, 17-methyl-, tartrate (1:1) (salt), (+)- .